Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CART-PSMA
i
Other names:
CART-PSMA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Nova Therap
Drug class:
PSMA-targeted CAR-T immunotherapy
Related drugs:
‹
AUTO7 (1)
CART-PSMA- TGFβRDN cells (0)
GD2, PSMA and CD276 CAR-T (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
TmPSMA-02 (0)
engineered autologous T cells (0)
multi-CAR-T cell therapy (0)
AUTO7 (1)
CART-PSMA- TGFβRDN cells (0)
GD2, PSMA and CD276 CAR-T (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
TmPSMA-02 (0)
engineered autologous T cells (0)
multi-CAR-T cell therapy (0)
›
Associations
News
Trials
Filter by
Latest
7d
CART-PSMA Cells for Advanced Prostate Cancer (clinicaltrials.gov)
P1, N=20, Recruiting, Nova Therapeutics LLC | Trial primary completion date: Dec 2024 --> Dec 2025
7 days ago
Trial primary completion date • Metastases
|
FOLH1 expression
|
cyclophosphamide • CART-PSMA
almost2years
CART-PSMA Cells for Advanced Prostate Cancer (clinicaltrials.gov)
P1, N=20, Recruiting, Nova Therapeutics LLC
almost 2 years ago
New P1 trial • Metastases
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
FOLH1 expression
|
cyclophosphamide • CART-PSMA
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login